Aflac Incorporated (NYSE:AFL) Director Joseph L. Moskowitz Sells 600 Shares

Aflac Incorporated (NYSE:AFL) Director Joseph L. Moskowitz sold 600 shares of the firm’s stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of $84.84, for a total value of $50,904.00. Following the completion of the transaction, the director now owns 27,550 shares in the company, valued at $2,337,342. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Aflac Stock Performance

NYSE:AFL opened at $86.08 on Monday. The stock has a 50-day moving average price of $83.62 and a 200 day moving average price of $82.12. The stock has a market capitalization of $48.91 billion, a P/E ratio of 9.50, a P/E/G ratio of 2.29 and a beta of 0.91. Aflac Incorporated has a 12-month low of $64.10 and a 12-month high of $86.26. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.34.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Monday, May 6th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.08. Aflac had a net margin of 27.67% and a return on equity of 16.88%. The business had revenue of $5.44 billion during the quarter, compared to analyst estimates of $4.09 billion. During the same period last year, the firm posted $1.55 EPS. The company’s revenue was up 13.3% on a year-over-year basis. Equities research analysts forecast that Aflac Incorporated will post 6.46 EPS for the current fiscal year.

Aflac Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 3rd. Shareholders of record on Wednesday, May 22nd will be issued a $0.50 dividend. This is an increase from Aflac’s previous quarterly dividend of $0.42. This represents a $2.00 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date of this dividend is Tuesday, May 21st. Aflac’s payout ratio is currently 22.08%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in AFL. Fortitude Family Office LLC purchased a new position in Aflac during the 4th quarter valued at approximately $25,000. Atwood & Palmer Inc. grew its holdings in shares of Aflac by 80.0% in the first quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 140 shares in the last quarter. OFI Invest Asset Management bought a new stake in Aflac in the first quarter worth $29,000. Bruce G. Allen Investments LLC purchased a new stake in Aflac during the fourth quarter valued at $32,000. Finally, Harvest Fund Management Co. Ltd bought a new position in Aflac during the third quarter valued at $33,000. Institutional investors own 67.44% of the company’s stock.

Wall Street Analysts Forecast Growth

AFL has been the topic of a number of recent research reports. Truist Financial increased their target price on Aflac from $80.00 to $82.00 and gave the company a “hold” rating in a report on Friday, May 3rd. Piper Sandler raised their price objective on shares of Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, April 5th. Wells Fargo & Company upped their target price on shares of Aflac from $81.00 to $82.00 and gave the company an “equal weight” rating in a report on Friday. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, May 3rd. Finally, Raymond James upped their price objective on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $82.38.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.